Lumican was shown to inhibit angiogenesis in various tumors [7]; however, the utilization of the 4T1 BC model demonstrated lumican attenuated 4T1 tumor growth and lung metastasis, but not angiogenesis [157]. This evidence concerns the gene LUM and breast cancer.